The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000180.4(GUCY2D):c.1343C>A (p.Ser448Ter)

CA226043

98540 (ClinVar)

Gene: GUCY2D
Condition: GUCY2D-related recessive retinopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: 36b13eab-bc25-4d08-8044-bd6407e0e7e8
Approved on: 2025-01-31
Published on: 2025-01-31

HGVS expressions

NM_000180.4:c.1343C>A
NM_000180.4(GUCY2D):c.1343C>A (p.Ser448Ter)
NC_000017.11:g.8006679C>A
CM000679.2:g.8006679C>A
NC_000017.10:g.7909997C>A
CM000679.1:g.7909997C>A
NC_000017.9:g.7850722C>A
NG_009092.1:g.9010C>A
ENST00000254854.5:c.1343C>A
ENST00000254854.4:c.1343C>A
NM_000180.3:c.1343C>A
More

Pathogenic

Met criteria codes 3
PM2_Supporting PVS1 PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Leber Congenital Amaurosis/early onset Retinal Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GUCY2D Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Leber Congenital Amaurosis/early onset Retinal Dystrophy VCEP
NM_000180.4(GUCY2D):c.1343C>A (p.Ser448Ter) is a nonsense variant that introduces a premature stop codon into exon 4 of 20, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v.4.1.0 at a total allele frequency of 0.00001242, with 20 alleles / 1610586 total alleles, which is lower than the ClinGen LCA/eoRD VCEP PM2_Supporting threshold of <0.0002 (PM2_Supporting). At least one proband harboring this variant exhibits a phenotype including diagnosis of Leber congenital amaurosis (0.5 pts) during the first year of life (1 pt), as well as nystagmus (1 pt), non-recordable electroretinogram responses from both rods (0.5 pts) and cones (1 pt), and normal fundus, which together are specific for GUCY2D-related recessive retinopathy (total 4 points, PMID: 10951519, PP4). In summary, this variant meets the criteria to be classified as pathogenic for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: PVS1, PM2_Supporting, and PP4. (VCEP specifications version 1.0.0; date of approval 01/22/2025).
Met criteria codes
PM2_Supporting
This variant is present in gnomAD v.4.1.0 at a total allele frequency of 0.00001242, with 20 alleles / 1610586 total alleles, which is lower than the ClinGen LCA/eoRD VCEP PM2_Supporting threshold of <0.0002 (PM2_Supporting).
PVS1
This is a nonsense variant that introduces a premature stop codon into exon 4 of 20, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1).
PP4
At least one proband harboring this variant exhibits a phenotype including diagnosis of Leber congenital amaurosis (0.5 pts) during the first year of life (1 pt), as well as nystagmus (1 pt), non-recordable electroretinogram responses from both rods (0.5 pts) and cones (1 pt), and normal fundus, which together are specific for GUCY2D-related recessive retinopathy (total 4 points, PMID: 10951519, PP4).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.